Showing 1 - 20 results of 39 for search 'Laughlin, M', query time: 0.06s
Refine Results
-
1
'Movie-made generation': cinema-going and the novel in post-war Britain by McLaughlin, M
Published 2014Thesis -
2
Review: Magnus Marsden (ed.), Islam and society in Pakistan: anthropological perspectives by McLaughlin, M
Published 2013Journal article -
3
Ideology, censorship and translation across genres: past and present by McLaughlin, M, Muñoz-Basols, J
Published 2016Journal article -
4
Imitation in literary theory and practice in Italy, 1400-1530 by McLaughlin, M, McLaughlin, Martin
Published 1984Thesis -
5
On the detectability of extragalactic fast radio transients by Lorimer, DR, Karastergiou, A, McLaughlin, M, Johnston, S
Published 2013Journal article -
6
Mild, calcium catalysed Beckmann rearrangements by Kiely-Collins, H, Sechi, I, Brennan, P, McLaughlin, M
Published 2017Journal article -
7
Radio polarization measurements from RRAT J1819-1458 by Karastergiou, A, Hotan, A, Straten, W, McLaughlin, M, Ord, S
Published 2009Journal article -
8
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. by Wilcock, G, Black, SE, Hendrix, S, Zavitz, K, Swabb, E, Laughlin, M
Published 2008Journal article -
9
Radio polarization measurements from RRAT J1819-1458 by Karastergiou, A, Hotan, A, van Straten, W, McLaughlin, M, Ord, S
Published 2009Journal article -
10
-
11
-
12
Simultaneous radio and X-ray observations of PSR B0611+22 by Rajwade, K, Seymour, A, Lorimer, D, Karastergiou, A, Serylak, M, McLaughlin, M, Griessmeier, J
Published 2016Journal article -
13
Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind tr... by Wilcock, G, Black, S, Haworth, J, Laughlin, M, Hendrix, S, Binger, M, Zavitz, K, Swabb, E, Hobden, A
Published 2005Journal article -
14
Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study by Black, S, Wilcock, G, Haworth, J, Hendrix, S, Zavitz, K, Christensen, D, Binger, M, Bass, S, Laughlin, M, Swabb, E
Published 2006Conference item -
15
Efficacy and safety of MPC-7869 (R-flurbiprofen), a Selective AB42-Lowering Agent, in Alzheimer's disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study. by Laughlin, M, Black, SE, Wilcock, G, Haworth, J, Hendrix, S, Zavitz, K, Christensen, D, Binger, M, Bass, S, Edward, S
Published 2006Conference item -
16
-
17
-
18
Development and validation of manually modified and supervised machine learning clinical assessment algorithms for malaria in Nigerian children by McLaughlin, M, Pellé, KG, Scarpino, SV, Giwa, A, Mount-Finette, E, Haidar, N, Adamu, F, Ravi, N, Thompson, A, Heath, B, Dittrich, S, Finette, B
Published 2022Journal article -
19
-
20